PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB/CD44 pathway

Yaling Zheng(Shanghai East Hospital), Yue Zhang(Shanghai East Hospital), Luran Xu(Shanghai East Hospital), Tianrui Zhu(Shanghai East Hospital), Gang Li(Southwest University)
International Immunopharmacology
December 3, 2023
Cited by 17


Related Papers